{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:41:04Z","timestamp":1789497664547,"version":"build-2803163510"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>extended curettage is generally used to treat infiltrative bone tumours. However, the extent of the curettage performed in previous studies remains unclear. This study aimed to investigate the efficacy of extended curettage for bone tumour-induced osteomalacia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>we included 12 patients with tumour-induced osteomalacia who underwent extended curettage at our hospital between 2000 and 2022. Extended curettage was applied in cases where tumour resection could cause functional impairment or necessitate complex reconstruction. We investigated patients\u2019 clinical and oncological outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>patients had a mean age of 55 (24\u201381) years, and the median follow-up duration after surgery was 3.9 (1.0\u201314.0) years. The causative tumours were located in the pelvis and lumbar spine. Imaging revealed the tumours to be of the sclerotic, intertrabecular, lytic and mixed types. Intraoperative 3D fluoroscopy was used in 10 patients. Extended curettage with high-speed burring and adjuvant therapy with cauterization using an electric scalpel and ethanol resulted in a remission rate of 83%; no recurrence or metastasis was observed in cases of early postoperative biochemical remission. In cases where the causative tumour was at the lumbar spine and ischium close to the acetabulum, no postoperative biochemical remission was observed, and conservative treatment was continued. Except for one patient with a tumour in the lumbar spine, all patients could walk without a cane.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>extended curettage for bone tumour-induced osteomalacia is oncologically and functionally favourable, especially in cases where resection of the causative tumour could cause functional impairment or necessitate complex reconstruction.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jjco\/hyad180","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T18:43:15Z","timestamp":1706121795000},"page":"463-470","source":"Crossref","is-referenced-by-count":3,"title":["Extended curettage for tumour-induced osteomalacia in the bone"],"prefix":"10.1093","volume":"54","author":[{"given":"Koichi","family":"Okajima","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8060-7309","authenticated-orcid":false,"given":"Hiroshi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, The University of Tokyo Hospital , Tokyo , Japan"},{"name":"Osteoporosis Center, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, The University of Tokyo Hospital , Tokyo , Japan"},{"name":"Osteoporosis Center, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0656-2365","authenticated-orcid":false,"given":"Liuzhe","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakae","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"2024040806014001700_ref1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3803\/EnM.2014.29.2.136","article-title":"Diagnostic modalities for FGF23-producing tumors in patients with tumor-induced osteomalacia","volume":"29","author":"Fukumoto","year":"2014","journal-title":"Endocrinol Metab"},{"key":"2024040806014001700_ref2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA"},{"key":"2024040806014001700_ref3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00223-022-01005-8","article-title":"Tumor-induced osteomalacia: a systematic clinical review of 895 cases","volume":"111","author":"Bosman","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"2024040806014001700_ref4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases","volume":"64","author":"Feng","year":"2017","journal-title":"Endocr J"},{"key":"2024040806014001700_ref5","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/jbmr.4620","article-title":"Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance","volume":"37","author":"Hidaka","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2024040806014001700_ref6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jbmr.3903","article-title":"Nonremission and recurrent tumor-induced osteomalacia: a retrospective study","volume":"35","author":"Li","year":"2020","journal-title":"J Bone Miner Res"},{"key":"2024040806014001700_ref7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12891-015-0496-3","article-title":"Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors","volume":"16","author":"Sun","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"2024040806014001700_ref8","doi-asserted-by":"crossref","first-page":"626272","DOI":"10.3389\/fsurg.2021.626272","article-title":"Management of the cavity after removal of giant cell tumor of the bone","volume":"8","author":"Wang","year":"2021","journal-title":"Front Surg"},{"key":"2024040806014001700_ref9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jos.2019.02.005","article-title":"Infiltrative nature of tumor-induced osteomalacia lesions in bone: correlation between radiological and histopathological features","volume":"24","author":"Kobayashi","year":"2019","journal-title":"J Orthop Sci"},{"key":"2024040806014001700_ref10","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2106\/JBJS.N.01299","article-title":"Surgical treatments of tumor-induced osteomalacia lesions in long bones: seventeen cases with more than one year of follow-up","volume":"97","author":"Wang","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"2024040806014001700_ref11","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1007\/s11999-013-3178-1","article-title":"The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?","volume":"471","author":"Ledford","year":"2013","journal-title":"Clin Orthop Relat Res"},{"key":"2024040806014001700_ref12","first-page":"22","article-title":"Tumor-induced osteomalacia treated with T12 tumor resection","volume":"2022","author":"Mancini","year":"2022","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"2024040806014001700_ref13","article-title":"Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: a case report","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine"},{"key":"2024040806014001700_ref14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3171\/2010.11.SPINE09750","article-title":"Oncogenic osteomalacia of the cervical spine: a rare case of curative resection and reconstruction","volume":"14","author":"Akhter","year":"2011","journal-title":"J Neurosurg Spine"},{"key":"2024040806014001700_ref15","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1530\/EC-19-0341","article-title":"Tumor induced osteomalacia in head and neck region: single center experience and systematic review","volume":"8","author":"Shah","year":"2019","journal-title":"Endocr Connect"},{"key":"2024040806014001700_ref16","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1210\/jc.2013-2528","article-title":"Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy","volume":"98","author":"Tarasova","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2024040806014001700_ref17","article-title":"Effects of burosumab on osteocalcin and bone mineral density in patient with 15-year history of nonremission tumor-induced osteomalacia initially treated with conventional therapy: case report","volume":"13","author":"Miyaoka","year":"2020","journal-title":"Bone Rep"},{"key":"2024040806014001700_ref18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000307468","article-title":"Treatment of recurrent intracranial hemangiopericytoma with SRC-related tyrosine kinase targeted therapy: a case report","volume":"3","author":"Peters","year":"2010","journal-title":"Case Rep Oncol"},{"key":"2024040806014001700_ref19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Miner Res"},{"key":"2024040806014001700_ref20","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10178","article-title":"Successful management of tumor-induced osteomalacia with radiofrequency ablation: a case series","volume":"3","author":"Mishra","year":"2019","journal-title":"JBMR Plus"},{"key":"2024040806014001700_ref21","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1210\/jc.2013-4515","article-title":"Radiofrequency ablation, an effective modality of treatment in tumor-induced osteomalacia: a case series of three patients","volume":"99","author":"Jadhav","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2024040806014001700_ref22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1159\/000510334","article-title":"Peptide receptor radionuclide therapy for a phosphaturic mesenchymal tumor","volume":"13","author":"H\u00e4fliger","year":"2020","journal-title":"Case Rep Oncol"},{"key":"2024040806014001700_ref23","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/jbmr.3219","article-title":"Multimodality image-guided cryoablation for inoperable tumor-induced osteomalacia","volume":"32","author":"Tella","year":"2017","journal-title":"J Bone Miner Res"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/54\/4\/463\/57174486\/hyad180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/54\/4\/463\/57174486\/hyad180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T06:02:39Z","timestamp":1712556159000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/54\/4\/463\/7585873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,1,23]]},"published-print":{"date-parts":[[2024,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyad180","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,1,23]]}}}